Cited by 369Pulmonary Hypertension Research and TreatmentsNitric Oxide and Endothelin EffectsVascular Anomalies and Treatments

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension

Xu, Weiling, Kaneko, F. Takao, Zheng, Shuo, Comhair, Suzy A. A., Janocha, Allison J., Goggans, Tannishia, Thunnissen, Frederik B. J. M., Farver, Carol, Hazen, Stanley L., Jennings, Constance, Dweik, Raed A., Arroliga, Alejandro C., Erzurum, Serpil C.·2004·The FASEB Journal

DOI 10.1096/fj.04-2317fje

Open this paper in CoChat — free account

Abstract

Pulmonary arterial hypertension (PAH), a fatal disease of unknown etiology characterized by impaired regulation of pulmonary hemodynamics and vascular growth, is associated with low levels of pulmonary nitric oxide (NO). Based upon its critical role in mediating vasodilation and cell growth, decrease of NO has been implicated in the pathogenesis of PAH. We evaluated mechanisms for low NO and pulmonary hypertension, including NO synthases (NOS) and factors regulating NOS activity, i.e. the substrate arginine, arginase expression and activity, and endogenous inhibitors of NOS in patients with PAH and healthy controls. PAH lungs had normal NOS I–III expression, but substrate arginine levels were inversely related to pulmonary artery pressures. Activity of arginase, an enzyme that regulates NO biosynthesis through effects on arginine, was higher in PAH serum than in controls, with high‐level arginase expression localized by immunostaining to pulmonary endothelial cells. Further, pulmonary artery endothelial cells derived from PAH lung had higher arginase II expression and produced lower NO than control cells in vitro. Thus, substrate availability affects NOS activity and vasodilation, implicating arginase II and alterations in arginine metabolic pathways in the pathophysiology of PAH.

Integrity signals

Registry

Crossref · 10.1096/fj.04-2317fje

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Primary Pulmonary Hypertension
Rich, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., Detre, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,027
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., & Saleh, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,366
Cellular and molecular mechanisms of endothelial cell dysfunction.
Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119751 · Cited by 1,059
Mammalian nitric oxide synthases
Stuehr, D. J. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00016-x · Cited by 996
Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein.
Stuehr, D. J., Cho, H. J., Kwon, N. S., Weise, M. F., & Nathan, C. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7773 · Cited by 816
Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine
Drexler, H., Zeiher, A. M., Meinzer, K., & Just, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)92372-9 · Cited by 794

Show all 75 references

Sorted by citations

Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Förstermann, U., & Münzel, T. (2006) · Circulation · doi:10.1161/circulationaha.105.602532 · Cited by 1,957
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 881
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Morrell, N. W., Adnot, S., Archer, S. L., Dupuis, J., Jones, P. L., MacLean, M. R., McMurtry, I. F., Stenmark, K. R., Thistlethwaite, P. A., Weißmann, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.018 · Cited by 832
Nitric oxide and oxidative stress in vascular disease
Förstermann, U. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0808-2 · Cited by 796
Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 769
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 672
Nitric Oxide and Endothelial Dysfunction
Cyr, A. R., Huckaby, L. V., Shiva, S. S., & Zuckerbraun, B. S. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2019.12.009 · Cited by 712
Endothelial Cell Metabolism
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2017) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 614
ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION
Durante, W., Johnson, F. K., & Johnson, R. A. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04638.x · Cited by 577
Strategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Arginase: A Multifaceted Enzyme Important in Health and Disease
Caldwell, R. W., Rodriguez, P. C., Toque, H. A., Narayanan, S. P., & Caldwell, R. B. (2018) · Physiological Reviews · doi:10.1152/physrev.00037.2016 · Cited by 495
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Tsai, E. J., & Kass, D. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.009 · Cited by 437
Alterations of cellular bioenergetics in pulmonary artery endothelial cells
Xu, W., Koeck, T., Lara, A., Neumann, D. R., DiFilippo, F. P., Koo, M., Janocha, A. J., Masri, F. A., Arroliga, A. C., Jennings, C. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605080104 · Cited by 401
Self-citation
Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension
Masri, F. A., Xu, W., COMHAIR, S. A. A., Asosingh, K., Koo, M., Vasanji, A., Drazba, J. A., Anand‐Apte, B., & ERZURUM, S. C. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00428.2006 · Cited by 383
Self-citation
Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans
ERZURUM, S. C., Ghosh, S., Janocha, A. J., Xu, W., Bauer, S. M., Bryan, N. S., Tejero, J., Hemann, C. F., Hille, R., Stuehr, D. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707462104 · Cited by 369
Self-citation
Arginase: an old enzyme with new tricks
Caldwell, R. B., Toque, H. A., Narayanan, S. P., & Caldwell, R. W. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.006 · Cited by 358
Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Evans, C. E., Cober, N. D., Dai, Z., Stewart, D. J., & Zhao, Y. (2021) · European Respiratory Journal · doi:10.1183/13993003.03957-2020 · Cited by 336
Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
Pernow, J., & Jung, C. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt036 · Cited by 318
Use of Exhaled Nitric Oxide Measurement to Identify a Reactive, at-Risk Phenotype among Patients with Asthma
Dweik, R. A., Sorkness, R. L., Wenzel, S. E., Hammel, J., Curran‐Everett, D., COMHAIR, S. A. A., Bleecker, E. R., Busse, W. W., Calhoun, W. J., Castro, M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0695oc · Cited by 267
Self-citation
Hypoxia Inducible-Factor1α Regulates the Metabolic Shift of Pulmonary Hypertensive Endothelial Cells
Fijałkowska, I. J., Xu, W., COMHAIR, S. A. A., Janocha, A. J., Mavrakis, L. A., Krishnamachary, B., Zhen, L., Mao, T., Richter, A., ERZURUM, S. C., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090832 · Cited by 268
Self-citation
Redox Control of Asthma: Molecular Mechanisms and Therapeutic Opportunities
COMHAIR, S. A. A., & ERZURUM, S. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2425 · Cited by 254
Self-citation
Endothelial Arginase II: A Novel Target for the Treatment of Atherosclerosis
Ryoo, S., Gupta, G., Benjo, A., Lim, H. K., Camara, A., Sikka, G., Lim, H. K., Sohi, J., Santhanam, L., Soucy, K., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.169573 · Cited by 236
Therapeutic Use of Citrulline in Cardiovascular Disease
Romero, M. J., Platt, D. H., Caldwell, R. B., & Caldwell, R. W. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00275.x · Cited by 231
Nitric Oxide Deficiency and Endothelial Dysfunction in Pulmonary Arterial Hypertension
Klinger, J. R., Abman, S. H., & Gladwin, M. T. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0686pp · Cited by 233
The Pharmacodynamics of L-Arginine
Böger, R. H. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1650s · Cited by 221
Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities
Kietadisorn, R., Juni, R. P., & Moens, A. L. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00540.2011 · Cited by 221
Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease
Goveia, J., Stapor, P. C., & Carmeliet, P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404156 · Cited by 203
Inflammatory cytokines in pulmonary hypertension
Groth, A., Vrugt, B., Brock, M., Speich, R., Ulrich, S., & Huber, L. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-47 · Cited by 198
Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension
Rajkumar, R., Konishi, K., Richards, T. J., Ishizawar, D. C., Wiechert, A. C., Kaminski, N., & Ahmad, F. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00254.2009 · Cited by 198
Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia
Morris, C. R. (2008) · Hematology · doi:10.1182/asheducation-2008.1.177 · Cited by 198
Activation of Alveolar Macrophages via the Alternative Pathway in Herpesvirus-Induced Lung Fibrosis
Mora, A. L., Torres-González, E., Rojas, M. M., Corredor-Medina, C., Ritzenthaler, J. D., Xu, J., Roman, J., Brigham, K. L., & Stecenko, A. A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0121oc · Cited by 191
Metabolism in Pulmonary Hypertension
Xu, W., Janocha, A. J., & ERZURUM, S. C. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-123956 · Cited by 194
Self-citation
Endothelial Dysfunction Driven by Hypoxia—The Influence of Oxygen Deficiency on NO Bioavailability
Janaszak‐Jasiecka, A., Siekierzycka, A., Płoska, A., Dobrucki, I. T., & Kalinowski, L. (2021) · Biomolecules · doi:10.3390/biom11070982 · Cited by 197
Nitrotyrosine Proteome Survey in Asthma Identifies Oxidative Mechanism of Catalase Inactivation
Ghosh, S., Janocha, A. J., Aronica, M. A., Swaidani, S., COMHAIR, S. A. A., Xu, W., Zheng, L., Kaveti, S., Kinter, M. T., Hazen, S. L., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5587 · Cited by 191
Self-citation
Recent Advances in Understanding Endothelial Dysfunction in Atherosclerosis
Yang, Z., & Ming, X. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.1.53 · Cited by 191
HIF2α–arginase axis is essential for the development of pulmonary hypertension
Cowburn, A. S., Crosby, A., Macías, D., Branco, C. M., Colaço, R., Southwood, M. R., Toshner, M. R., Alexander, L. E. C., Morrell, N. W., Chilvers, E. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602978113 · Cited by 187
Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains
Culley, M. K., & Chan, S. Y. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120847 · Cited by 178
Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats
White, A. R., Ryoo, S., Li, D., Champion, H. C., Steppan, J., Wang, D., Nyhan, D. P., Shoukas, A. A., Hare, J. M., & Berkowitz, D. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000198543.34502.d7 · Cited by 179
Oxidized Low-Density Lipoprotein–Dependent Endothelial Arginase II Activation Contributes to Impaired Nitric Oxide Signaling
Ryoo, S., Lemmon, C. A., Soucy, K. G., Gupta, G., White, A. R., Nyhan, D. P., Shoukas, A. A., Romer, L. H., & Berkowitz, D. E. (2006) · Circulation Research · doi:10.1161/01.res.0000247034.24662.b4 · Cited by 174
Soluble Guanylate Cyclase Stimulators in Pulmonary Hypertension
Stasch, J., & Evgenov, O. V. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-38664-0_12 · Cited by 168
Arginase and vascular aging
Santhanam, L., Christianson, D. W., Nyhan, D. P., & Berkowitz, D. E. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90627.2008 · Cited by 166
Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine
Morris, C. R., Hamilton‐Reeves, J. M., Martindale, R. G., Sarav, M., & Ochoa, J. B. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617691250 · Cited by 162
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
Hoeper, M. M., Simonneau, G., Corris, P. A., Ghofrani, H. A., Klinger, J. R., Langleben, D., Naeije, R., Jansa, P., Rosenkranz, S., Scelsi, L., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02425-2016 · Cited by 158
Evidence for Rho-Kinase Activation in Patients With Pulmonary Arterial Hypertension
Do.e, Z., Fukumoto, Y., Takaki, A., Tawara, S., Ohashi, J., Nakano, M., Tada, T., Saji, K., Sugimura, K., Fujita, H., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0135 · Cited by 157
Hypoxia-inducible factor pathway and diseases of the vascular wall
Lim, C. S., Kiriakidis, S., Sandison, A., Paleolog, E. M., & Davies, A. H. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.02.240 · Cited by 154
Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders
Gielis, J. F., Lin, J. Y., Wingler, K., Schil, P. E. V., Schmidt, H. H. H. W., & Moens, A. L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.018 · Cited by 158
Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal
Förstermann, U. (2006) · Biological Chemistry · doi:10.1515/bc.2006.190 · Cited by 155
Metabolic reprogramming, oxidative stress, and pulmonary hypertension
Pokharel, M. D., Marciano, D. P., Fu, P., Franco, M. C., Unwalla, H. J., Tieu, K., Fineman, J. R., Wang, T., & Black, S. M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102797 · Cited by 157
Arginase and pulmonary diseases
Maarsingh, H., Pera, T., & Meurs, H. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0286-7 · Cited by 146
Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension
Girgis, R. E., Champion, H. C., Diette, G. B., Johns, R. A., Permutt, S., & SYLVESTER, J. T. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1684oc · Cited by 144
Arginase Inhibitors: A Rational Approach Over One Century
Pudlo, M., Demougeot, C., & Girard, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21419 · Cited by 151
Asymmetric Dimethylarginine Induces Oxidative and Nitrosative Stress in Murine Lung Epithelial Cells
Wells, S. M., & Holian, A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0302sm · Cited by 144
Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia
Fresquet, F., Pourageaud, F., Leblais, V., Brandes, R. P., Savineau, J., Marthan, R., & Müller, B. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706779 · Cited by 142
Amplified Expression Profiling of Platelet Transcriptome Reveals Changes in Arginine Metabolic Pathways in Patients With Sickle Cell Disease
Raghavachari, N., Xu, X., Harris, A. B., Villagra, J. D., Logun, C., Barb, J. J., Solomon, M. A., Suffredini, A. F., Danner, R. L., Kato, G. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.658641 · Cited by 141
Increased mitochondrial arginine metabolism supports bioenergetics in asthma
Xu, W., Ghosh, S., COMHAIR, S. A. A., Asosingh, K., Janocha, A. J., Mavrakis, D. A., Bennett, C. D., Gruca, L. L., Graham, B. B., Queisser, K. A., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82925 · Cited by 138
Self-citation
Arginase: The Emerging Therapeutic Target for Vascular Oxidative Stress and Inflammation
Yang, Z., & Ming, X. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00149 · Cited by 133
Abnormalities in nitric oxide and its derivatives in lung cancer
Masri, F. A., Comhair, S. A. A., Koeck, T., Xu, W., Janocha, A., Ghosh, S., Dweik, R. A., Golish, J., Kinter, M., Stuehr, D. J., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1523oc · Cited by 128
Self-citation
From arginine methylation to ADMA: A novel mechanism with therapeutic potential in chronic lung diseases
Zakrzewicz, D., & Eickelberg, O. (2009) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-9-5 · Cited by 125
Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes
Menge, B. A., Schrader, H., Ritter, P. R., Ellrichmann, M., Uhl, W. H., Schmidt, W. E., & Meier, J. J. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.08.001 · Cited by 126
Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease
Horowitz, S. A., Binion, D. G., Nelson, V. M., Kanaa, Y., Javadi, P., Lazarova, Z., Andrekopoulos, C., Kalyanaraman, B., Otterson, M. F., & Rafiee, P. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00499.2006 · Cited by 126
Role of arginine in superficial wound healing in man
Debats, I. B. J. G., Wolfs, T. G. A. M., Gotoh, T., Cleutjens, J. P. M., Peutz‐Kootstra, C. J., & van der Hulst, R. R. W. J. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.07.006 · Cited by 122
Insulin Reduces Plasma Arginase Activity in Type 2 Diabetic Patients
Kashyap, S., Lara, A., Zhang, R., Park, Y. M., & DeFronzo, R. A. (2007) · Diabetes Care · doi:10.2337/dc07-1198 · Cited by 125
The Nitric Oxide Pathway in Pulmonary Vascular Disease
Klinger, J. R., & Kadowitz, P. J. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.06.012 · Cited by 119
Exhaled breath analysis: the new frontier in medical testing
Dweik, R. A., & Amann, A. (2008) · Journal of Breath Research · doi:10.1088/1752-7163/2/3/030301 · Cited by 116
Self-citation
Nitric Oxide and Arginine Dysregulation: A Novel Pathway to Pulmonary Hypertension in Hemolytic Disorders
Morris, C. R., Gladwin, M. T., & Kato, G. J. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241447 · Cited by 116
Hemolysis‐Associated Pulmonary Hypertension in Thalassemia
Morris, C. R., Kuypers, F. A., Kato, G. J., Lavrisha, L., Larkin, S. K., SINGER, T., & Vichinsky, E. P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.058 · Cited by 112
Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases
Li, Z., Wang, L., Ren, Y., Huang, Y., Liu, W., Lv, Z., Lü, Q., Yu, Y., & Xiong, Y. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01200-4 · Cited by 118
Immune and inflammatory mechanisms in pulmonary arterial hypertension
Chami, H. E., & Hassoun, P. M. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.07.006 · Cited by 109
Perturbations of the arginine metabolome following exposures to traffic-related air pollution in a panel of commuters with and without asthma
Liang, D., Ladva, C. N., Golan, R., Yu, T., Walker, D. I., Sarnat, S. E., Greenwald, R., Uppal, K., Tran, V., Jones, D. P., et al. (2019) · Environment International · doi:10.1016/j.envint.2019.04.003 · Cited by 108
The role of polyamine metabolism in cellular function and physiology
Schibalski, R. S., Shulha, A. S., Tsao, B. P., Palygin, O., & Ilatovskaya, D. V. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00074.2024 · Cited by 118
Lung Vascular Cell Heterogeneity: Endothelium, Smooth Muscle, and Fibroblasts
Stevens, T., Phan, S. H., Frid, M. G., Alvarez, D. F., Herzog, E. L., & Stenmark, K. R. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200803-027hr · Cited by 107
AMINO ACIDS, ARGINASE AND NITRIC OXIDE IN VASCULAR HEALTH
Huynh, N., & Chin-Dusting, J. P. F. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04316.x · Cited by 108
Endothelial Cell Energy Metabolism, Proliferation, and Apoptosis in Pulmonary Hypertension
Xu, W., & ERZURUM, S. C. (2010) · Comprehensive physiology · doi:10.1002/cphy.c090005 · Cited by 123
Self-citation
Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction
Nicholls, S. J., Wang, Z., Koeth, R., Levison, B. S., DelFraino, B., Džavík, V., Griffith, O. W., Hathaway, D. R., Panza, J. A., Nissen, S. E., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.693986 · Cited by 107
Self-citation
Erythrocytosis and Pulmonary Hypertension in a Mouse Model of Human HIF2A Gain of Function Mutation
Tan, Q., Kerestes, H., Percy, M. J., Pietrofesa, R. A., Chen, L., Khurana, T. S., Christofidou‐Solomidou, M., Lappin, T. R. J., & Lee, F. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444059 · Cited by 104
Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension
Ghofrani, H. A., Humbert, M. J. C., Langleben, D., SCHERMULY, R. T., Stasch, J., Wilkins, M. R., & Klinger, J. R. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.05.024 · Cited by 103
Original insights on thrombospondin-1-related antireceptor strategies in cancer
Jeanne, A., Schneider, C., Martiny, L., & Dedieu, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00252 · Cited by 102
Mitochondrial Arginase II Modulates Nitric-Oxide Synthesis through Nonfreely Exchangeable l-Arginine Pools in Human Endothelial Cells
Topal, G., Brunet, A., Walch, L., Boucher, J., & David‐Dufilho, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103747 · Cited by 100
Human Primary Lung Endothelial Cells in Culture
COMHAIR, S. A. A., Xu, W., Mavrakis, L. A., Aldred, M. A., Asosingh, K., & ERZURUM, S. C. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0416te · Cited by 101
Self-citation
Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling
Zuckerbraun, B. S., George, M. P., & Gladwin, M. T. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq370 · Cited by 99
Reactive oxygen species induced Ca 2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension
Suresh, K. S., Servinsky, L. E., Jiang, H., Bigham, Z., Yun, X., Kliment, C. R., Huetsch, J., Damarla, M., & Shimoda, L. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00430.2017 · Cited by 102
Functional role and species-specific contribution of arginases in pulmonary fibrosis
Kitowska, K., Zakrzewicz, D., Königshoff, M., Chrobak, I., Grimminger, F., Seeger, W., Bulau, P., & Eickelberg, O. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00007.2007 · Cited by 99
Arginase in retinopathy
Narayanan, S. P., Rojas, M., Suwanpradid, J., Toque, H. A., Caldwell, R. W., & Caldwell, R. B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.06.002 · Cited by 96
Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease
Rogers, N. M., Sharifi‐Sanjani, M., Csányi, G., Pagano, P. J., & Isenberg, J. S. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.01.002 · Cited by 96
Role of Arginase in Vessel Wall Remodeling
Durante, W. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00111 · Cited by 94
Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes
Beleznai, T., Fehér, A., Spielvogel, D., Lansman, S. L., & Bagi, Z. A. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00831.2010 · Cited by 90
Uremic Toxins and Vascular Dysfunction
Six, I., Flissi, N., Lenglet, G., Louvet, L., Kamel, S., Gallet, M., Massy, Z. A., & Liabeuf, S. (2020) · Toxins · doi:10.3390/toxins12060404 · Cited by 97
Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase
Chen, B., Calvert, A. E., Cui, H., & Nelin, L. D. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00183.2009 · Cited by 88
Nitric oxide deficiency in pulmonary hypertension: pathobiology and implications for therapy
Tonelli, A. R., Haserodt, S., Aytekin, M., & Dweik, R. A. (2013) · Pulmonary Circulation · doi:10.4103/2045-8932.109911 · Cited by 86
Self-citation
Asthma management: Reinventing the wheel in sickle cell disease
Morris, C. R. (2009) · American Journal of Hematology · doi:10.1002/ajh.21359 · Cited by 87
Role of epithelial nitric oxide in airway viral infection
Xu, W., Zheng, S., Dweik, R. A., & Erzurum, S. C. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.037 · Cited by 85
Self-citation
Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension
Xu, W., COMHAIR, S. A. A., Chen, R., Hu, B., Hou, Y., Zhou, Y., Mavrakis, L. A., Janocha, A. J., Li, L., Zhang, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55053-6 · Cited by 84
Self-citation
The Nitric Oxide/cGMP Signaling Pathway in Pulmonary Hypertension
Klinger, J. R. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.12.002 · Cited by 84
Endothelial arginase: A new target in atherosclerosis
Yang, Z., & Ming, X. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0041-8 · Cited by 85
Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension
Costello, C. M., Howell, K., Cahill, E., McBryan, J., Königshoff, M., Eickelberg, O., Gaine, S., Martin, F., & McLoughlin, P. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00358.2007 · Cited by 84
Arginine metabolism in vascular biology and disease
Morris, S. M. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000112 · Cited by 85
High levels of hyaluronan in idiopathic pulmonary arterial hypertension
Aytekin, M., COMHAIR, S. A. A., de la Motte, C., Bandyopadhyay, S. K., Farver, C. F., Hascall, V., ERZURUM, S. C., & Dweik, R. A. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90306.2008 · Cited by 82
Self-citation

Authors: Xu, W., Kaneko, F. T., Zheng, S., Comhair, S. A. A., Janocha, A. J., Goggans, T., Thunnissen, F. B. J. M., Farver, C., Hazen, S. L., Jennings, C., Dweik, R. A., Arroliga, A. C., & Erzurum, S. C.
Affiliations: Cleveland Clinic (US)
Department of Pathology Canisius Wihelmina Ziekenhuis Nijmegen The Netherlands
ORCID: Xu, Weiling
Zheng, Shuo
Comhair, Suzy A. A.
Farver, Carol
Hazen, Stanley L.
Dweik, Raed A.
Arroliga, Alejandro C.
Erzurum, Serpil C.
Venue: The FASEB Journal
Publisher: Wiley
Published: 2004-09-13
Volume: 18
Issue: 14
Pages: 1746-1748
ISSN: 0892-6638 (ISSN-L)
1530-6860
DOI: 10.1096/fj.04-2317fje
OpenAlex: W2116905957
Cited by: 369
References: 75
Citations by year: 2026: 4 · 2025: 5 · 2024: 14 · 2023: 10 · 2022: 10 · 2021: 18 · 2020: 12 · 2019: 12 · 2018: 16 · 2017: 23 · 2016: 13 · 2015: 17 · 2014: 21 · 2013: 27 · 2012: 13
FWCI: 16.61
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: The FASEB Journal (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (HL 60917, HL 04265, HL076491)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
Keywords: pulmonary arterial hypertension, arginase II, nitric oxide production, nitric oxide synthase, arginine metabolism, endothelial cells, pulmonary artery endothelium, vasodilation, pulmonary hypertension pathogenesis, nitric oxide synthase inhibitors
MeSH terms: Arginase, Blood Pressure, Cells, Cultured, Endothelium, Vascular, Humans, Hypertension, Pulmonary, Nitric Oxide, Pulmonary Artery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks